Ignite Creation Date:
2024-05-06 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 2:54 PM
Study NCT ID:
NCT05774028
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-03-17
First Post:
2023-03-07
Brief Title:
Pegaspargase Combined With Gemcitabine Etoposide Liposomal Mitoxantrone Hydrochloride and Dexamethasone P-GEMD in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NKT-cell Lymphoma
Sponsor:
Organization:
The First Affiliated Hospital with Nanjing Medical University
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
50
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: